Second quarter net earnings of $25.5 million, or $0.22 per diluted share; adjusted earnings of $29.3 million, or $0.26 per diluted share Consolidated core EBITDA of $131.0 million in the second quarter; core EBITDA margin of 7.5% Solid North American construction demand drove a 3.3%…
Category: Uncategorized
Delivers full year 2024 EPS at high end of guidance range Fiscal 2025 guidance reflects expectations for profitable growth COLUMBUS, Ohio, March 20, 2025 /PRNewswire/ — Designer Brands Inc. (NYSE: DBI) (the “Company,” “we,” “us,” “our,” and “Designer Brands”), one of the world’s largest…
GUANGZHOU, China, March 20, 2025 /PRNewswire/ — HUYA Inc. (“Huya” or the “Company”) (NYSE: HUYA), a leading game live streaming platform in China, today announced that the New York Stock Exchange (“NYSE”) has set July 1, 2025 as the ex-dividend date for the Company’s cash dividend to be…
TORONTO, March 20, 2025 /PRNewswire/ – Denison Mines Corp. (“Denison” or the “Company”) (TSX: DML) (NYSE American: DNN) is pleased to announce the appointment of Ken Hartwick, who previously served as the CEO of Ontario Power Generation (‘OPG’), to its Board of Directors (the ‘Board’). Mr….
Quarterhill Inc. is a platinum sponsor and exhibitor at the IBTTA Technology Summit, a key platform for discussing the future of tolling technology, which will take place from March 22 to 25, 2025, in Dallas, Texas. At the IBTTA Technology Summit, Quarterhill will showcase advanced…
At booth 2319, VIAVI will showcase three new products supporting the transition to next-gen AI infrastructure CHANDLER, Ariz., March 20, 2025 /PRNewswire/ — VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced it will showcase its latest test solutions for AI infrastructure…
A 295,000+ patient study revealed variable efficacy among cancers for patients treated with tissue-agnostic drugs and uncovered the potential for expanding approvals to other drugs of the same class IRVING, Texas, March 20, 2025 /PRNewswire/ — Caris Life Sciences® (Caris), a leading…
COLUMBUS, Ohio, March 20, 2025 /PRNewswire/ — Paradigm Health, which is rebuilding the clinical research ecosystem, today announced the appointment of Karen E. Knudsen, MBA, PhD, to its Board of Directors, alongside the upcoming launch of its eSource clinical trial data application. Dr….
First patient dosed in Phase II OCULE-01 study with roginolisib, an allosteric modulator of PI3Kδ The European Medicines Agency (EMA) has granted Orphan Drug Designation for roginolisib for treatment of uveal melanoma – benefits include 10 years market exclusivity in the European Union…
Met een ruim aanbod vormfactoren kan Supermicro’s uitgebreide portfolio van PCIe GPU-systemen worden aangepast aan de meest veeleisende datacenterbehoeften, met tot 10 GPU’s met dubbele breedte tot Intelligent Edge-systemen met laag stroomverbruik die maximale flexibiliteit en…